Healthcare inflation in Singapore is projected to hit 16.9% in 2026, according to WTW’s 2026 Global Medical Trends study, up from 15.5% in 2025. Between 2021 and 2024, private hospital top-up policy premiums were compounding at 17% annually. Around 100,000 Singaporeans were cancelling or downgrading their cover every year. The Ministry of Health took action in late 2025, restructuring Integrated Shield Plan (IP) riders (optional add-ons), doubling copayment caps, and removing the ability to cover minimum deductibles. The goal? A 30% average premium reduction.

Many clients are redesigning plans rather than absorbing increased premiums

Jacklyn Tan, Head of Renewal, Employee Benefits at Howden Singapore, provided an insight into how employers are reacting to rising international private medical insurance (IPMI) premiums in Singapore. It seems they have stopped absorbing and started redesigning. “We see employers reassessing the sustainability of IPMI as medical premium inflation exceeds 10% per annum for these types of plans. IPMI’s advantages – global direct billing networks, higher limits, and comprehensive benefits – remain valued, especially for senior employees and foreign expatriates, but come at a higher premium cost,” she stated. “Many clients are redesigning plans rather than absorbing increased premiums. Rising premiums are driven by higher claims utilisation, medical inflation, advancement of medical technology and drugs, and an ageing population – pressures that affect not only IPMI but the general population. The overall shift is toward sustainability without losing strategic benefits for key talent segments.”

Richard Cooper, Mercer Marsh Benefits Leader for Singapore, said that a key driver was the growing impact of high-cost claims. “In Asia, 87% of insurers cite high-cost claimants as their top affordability concern, and 44% report more members hitting lifetime or annual limits. In response, employers are focusing on sustainability measures such as tiered networks, managed care, early detection and intervention, and targeted oversight of complex claims.”

Are copayments the answer?

Copayments, where employees contribute a fixed share of their treatment costs, are the obvious mechanism. But introduce them badly and you simply shift the burden without fixing the underlying problem. “In Singapore, copayment options are now widely accepted as a necessary lever to curb overutilisation and rebalance rising healthcare costs,” said Jacklyn Tan. “However, adoption is paced. We often see copayments introduced in the second year and beyond or phased in gradually. At the same time, management teams in many cases also perceive that premium rates have not sufficiently adjusted in line with the introduction of copays, prompting a measured approach.”

Cooper pointed out that there’s a difference between asking employees to share costs as part of a thought-through care strategy and simply passing the bill along: “Employers are applying these levers selectively. Many are combining cost-sharing with care navigation, tiered networks, or centre-of-excellence models to preserve access to high-quality care,” he stated. “Given Singapore’s excellent healthcare standard, the emphasis is less on blunt cost-shifting and more on encouraging use of Singapore’s more affordable public healthcare system and more measured consumption within the private one.”

Is Singapore still competitive?

Jacklyn Tan said that Singapore was among the most expensive medical markets in Asia, though it is not always the single most expensive on every measure. “Singapore’s healthcare environment is structurally expensive due to advanced care, utilisation, and limited price transparency,” she stated. “Employers value quality and reliability but are calibrating benefit design – especially private hospital access – to preserve sustainability while supporting employees.”

Cooper argued that the cost question was being framed too narrowly, as price is only part of what employers are buying: “Competitiveness should not be measured by cost alone. Employers continue to value Singapore’s clinical quality, predictability, and access to specialist care. The challenge is not Singapore’s attractiveness, but the need for disciplined benefit design, responsible consumption, and controlled utilisation management to ensure that rising costs do not erode long-term affordability.”

The view from the hospital side

Daniel Kastner, Chief Commercial Officer at Bumrungrad International Hospital in Bangkok, sees all of this from a different angle. Bumrungrad treats a meaningful volume of patients covered by Singapore-issued policies. But for now, the movement of patients is minimal: “At this stage, the direct impact has been relatively limited, as the changes are still recent. It typically takes time for patient behaviour to adjust and for alternatives, such as Thailand, to be considered instead of closer options like Malaysia,” stated Kastner. “That said, Bumrungrad is well known across the region as a leading medical tourism destination, and we have long-standing relationships with many corporates and insurers whose members regularly seek care with us.”

The overall shift is toward sustainability without losing strategic benefits for key talent segments

On the changing relationship between hospitals and insurers more broadly, Kastner is seeing genuine progress, but it’s also clear where it can go wrong: “There’s far more engagement now around care pathways, appropriate utilisation, and outcome data. Pre-authorisation used to feel adversarial on both sides,” he highlighted. “Now there’s a growing acceptance that clinical case management, done well, improves patient outcomes. 

The pushback comes when it’s done badly, as a blunt cost containment instrument rather than a clinical one.” The same cost pressures driving change in Singapore are rippling outward, though the response varies considerably by market: “Across Southeast Asia, insurers are facing growing pressure from medical inflation and rising utilisation that outpace general inflation and economic growth,” Kastner revealed. “In response, many are implementing cost containment measures such as preferred provider networks with bundled pricing, caps on price increases, deeper discounts, and more assertive claims management strategies.”

What makes Singapore distinctive?

Royston Tan, Head of Health and Benefits for Asia Pacific (APAC) at WTW, draws on the firm’s 2025 Global Mobility and Expatriate Benefits Survey conducted across employers in APAC and elsewhere. “Singapore’s approach is distinctive not because IPMI costs are lower, but because cost discipline has been more explicitly embedded into employer decision-making over time,” he stated. “Employers in this market have developed a long-standing discipline of anticipating and managing premium increases, instead of responding to them as episodic shocks.”

Insurers are facing growing pressure from medical inflation and rising utilisation that outpace general inflation and economic growth

While Singapore hasn’t solved the problem of medical inflation, employers have built it into their planning rather than treating each renewal as a surprise. These include emphasing benchmarking of benefit design, structured access to private care, and acceptance of cost sharing and plan controls. The WTW survey data puts the regional challenge in perspective. Managing rising costs ranked second among employer priorities for international health benefits across APAC: 18% named it their top concern, just behind compliance at 20%. More than 40% reported moderate to significant premium increases at their last renewal. Nearly 90% expect the number of internationally mobile staff they manage to stay flat or grow over the next 12 months.

Lessons for the region

Singapore isn’t a model to be replicated as the markets in the region are too different. But Royston Tan identified principles that do translate: “Early emphasis on structured plan design. Clear minimum benefit standards, with defined coverage parameters, cited as having a large or very large impact on expatriate policy design by nearly half of survey respondents. And acceptance of international plans for expatriates: around 75% of employers currently offer international healthcare benefits to expatriates, reinforcing IPMI’s central role in mobility programmes,” he stated. “For markets such as Thailand and Malaysia, adopting these principles earlier may help avoid later disruption as private healthcare costs accelerate. Companies in Vietnam tend to align their approach to IPMI provision with Singapore already.”

On the question of how multinationals manage benefits across countries with very different healthcare systems and costs, the answer is to agree on a minimum standard that all markets meet and allow local variation above that. “We see a consistent pattern among employers – setting regional principles and minimum standards, allowing country-level design, limits, and networks, and tightening governance and data without enforcing identical benefits,” stated Tan. “Due to country nuances in healthcare systems, costs, and regulation, strict alignment of benefits is generally not encouraged.”

Kastner shared what’s hardest to reproduce in markets like Thailand: “Singapore’s highly coordinated and unified approach would be the most difficult to replicate. In Thailand, regulatory and industry stakeholders tend to be more fragmented, which means achieving broad alignment and implementing sector-wide measures often takes more time.”

Cooper said that Malaysia was a market with real strengths, but familiar obstacles: “There’s a foundation to build on. The challenge is getting hospitals, insurers, and regulators to align on a shared framework for cost management without stifling the private sector growth that the country is also counting on.” 

Jacklyn Tan said that the gap was wider still in Indonesia and Vietnam: “The fundamentals that underpin Singapore’s IPMI evolution – reliable claims data, regulatory stability, a deep pool of insurer and broker expertise – don’t yet exist in the same form. That doesn’t mean the direction of travel is wrong; it means the sequencing matters enormously.”

Envisioning a sustainable market

So, what does a sustainable market really look like? One useful indicator is simply whether new players want in. Royston Tan noted that three new international health insurers had entered the Singapore market in the past 18 months, which is a sign that sophisticated operators see long-term demand, not a market in decline. “Sustainability is also where there is predictable rather than extreme premium movement, even when increases occur,” he said. “Employers should focus on plan design and proactive management, not just reactive renewal negotiation, with employee wellbeing, case management, and early intervention critical to ensuring sustainability over the longer term.”

Tan also pointed to the rise of Local Plus policies: a hybrid product that gives employees some of the international portability of a full IPMI plan, but at a significantly lower cost. As the gap between what employers want to offer and what they can sustainably fund widens, these products are emerging as a practical middle ground. Other markets in the region will encounter the same dynamic as their own cost pressures build.

Looking ahead

The structural pressures Singapore is working through now are heading for Thailand, Malaysia, Indonesia, and Vietnam regardless. The question is: are those markets ready? “IPMI sustainability in APAC is now tightly linked to employer governance, not just insurer pricing,” said Royston Tan. “With compliance, cost management, and benefit benchmarking all ranking ahead of voluntary enhancements, employers are signalling readiness for more disciplined models. Singapore’s experience shows that structure, transparency, and early intervention can support long-term viability without undermining assignee wellbeing. As Southeast Asian markets mature, those lessons are likely to become increasingly relevant,” he concluded.